Extravascular inflammation does not increase atherosclerosis in apoE-deficient mice

Area of Science:

• Cardiovascular Science
• Immunology
• Inflammation Research

Background:

• Atherosclerosis is a chronic inflammatory disease.
• The role of chronic extravascular inflammation in accelerating atherosclerosis remains unclear.
• Non-autoimmune inflammation models are crucial for studying this relationship.

Purpose of the Study:

• To investigate whether chronic extravascular inflammation accelerates atherosclerosis.
• To test this hypothesis in apolipoprotein E-deficient (apoE(-/-)) mice.
• To utilize three distinct models of chronic inflammation.

Main Methods:

• Employed three models: croton oil-induced skin inflammation, Aspergillus fumigatus-induced allergic lung disease, and A. fumigatus-induced peritonitis in apoE(-/-) mice.
• Monitored inflammatory markers such as IL-6 and serum amyloid A (SAA).
• Quantified aortic atherosclerosis using computer-assisted morphometry.

Main Results:

• Croton oil model showed skin ulceration and elevated IL-6 and SAA.
• Allergic lung disease model exhibited local inflammation, eosinophilia, and IgE.
• Peritonitis model had mild SAA elevation.
• Crucially, none of the inflammation models affected the rate of atherosclerosis development.

Conclusions:

• Chronic extravascular inflammation, independent of autoimmune processes, does not accelerate atherosclerosis in apoE(-/-) mice.
• These findings suggest that the location of inflammation is a critical factor in its impact on atherosclerosis.
• Further research may explore mechanisms linking localized inflammation to cardiovascular disease progression.